
|Videos|October 24, 2017
Role for Proton Therapy in Locally Advanced Non–Small-Cell Lung Cancer?
Author(s)Zhongxing Liao, MD
This video reviews results of a randomized trial comparing intensity modulated radiation therapy vs passively scattered proton therapy for locally advanced non–small-cell lung cancer.
Advertisement
In this video, Zhongxing Liao, MD, of MD Anderson Cancer Center in Houston, Texas, reviews results of a randomized trial that compared intensity modulated radiation therapy (IMRT) vs passively scattered proton therapy in patients with locally advanced non–small-cell lung cancer.
Liao gave a presentation on this topic earlier this year at the 2017 Multidisciplinary Thoracic Cancers Symposium.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Epcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma
2
Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer
3
GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology
4
Understanding The Training, Credentialing Landscapes for End-of-Life Doulas
5

























































